Federal reclassification of marijuana could have major impact on medical uses

The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying marijuana as a Schedule II drug, which would put it in the same category as Ritalin, Adderall and oxycodone. Kevin Hill (McLean) is quoted.

Read the full article